TickerLeague

EBITDA for Tempus AI (TEM)

According to Tempus AI's latest reported financial statements, the company's current EBITDA (TTM) is -$199.52M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

-$199.52M

YoY change

-63.6%

5Y CAGR

N/A

Peak year (2019)

-$99.90M

Cumulative EBITDA

-$1.69B

EBITDA history chart for Tempus AI (TEM) from 2019 to 2025

EBITDA history table for Tempus AI (TEM) from 2019 to 2025

Fiscal yearPeriod endedReportedEBITDAYoYYoY change
2025-$222.36M-63.6%+$388.06M
2024-$610.42M+357.8%-$477.09M
2023-$133.33M-43.7%+$103.52M
2022-$236.85M+7.9%-$17.32M
2021-$219.52M+29.6%-$50.15M
2020-$169.37M+69.5%-$69.47M
2019-$99.90M

EBITDA values are taken from Tempus AI's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Tempus AI (TEM) EBITDA totalled -$222.36M – plunged 63.6% year-over-year.

2019 marks the peak EBITDA at -$99.90M, with the historical low of -$610.42M recorded in 2024.

Within Healthcare, Tempus AI (TEM) ranks 9th among 8 peers we track. The peer median for EBITDA is $25.50B.

Tempus AI EBITDA by Year

Tempus AI EBITDA 2025: -$222.36M

Tempus AI EBITDA in 2025 was -$222.36M, plunged 63.6% below 2024.

Tempus AI EBITDA 2024: -$610.42M

Tempus AI EBITDA in 2024 was -$610.42M, surged 357.8% from 2023. This figure represents the lowest annual value in the available history.

Tempus AI EBITDA 2023: -$133.33M

Tempus AI EBITDA in 2023 was -$133.33M, plunged 43.7% below 2022.

Tempus AI EBITDA 2022: -$236.85M

Tempus AI EBITDA in 2022 was -$236.85M, grew 7.9% from 2021.

Tempus AI EBITDA 2021: -$219.52M

Tempus AI EBITDA in 2021 was -$219.52M.

See more financial history for Tempus AI (TEM).

Sector peers — EBITDA

Companies in the same sector as Tempus AI, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Merck & Co. (MRK)$29.32BHealthcare
Eli Lilly (LLY)$27.94BHealthcare
UnitedHealth Group (UNH)$23.06BHealthcare
AstraZeneca (AZN)$19.83BHealthcare
AbbVie (ABBV)$17.63BHealthcare
Amgen (AMGN)$15.84BHealthcare

Frequently asked questions

What is Tempus AI's EBITDA?

Latest reported EBITDA for Tempus AI (TEM) is -$199.52M (period ending March 31, 2026).

How has Tempus AI EBITDA changed year-over-year?

Tempus AI (TEM) EBITDA changed -63.6% year-over-year on the latest annual filing.

When did Tempus AI EBITDA hit its highest annual value?

Tempus AI EBITDA reached its highest annual value of -$99.90M in 2019.

What was Tempus AI EBITDA in 2024?

Tempus AI (TEM) EBITDA in 2024 was -$610.42M.

What was Tempus AI EBITDA in 2025?

Tempus AI (TEM) EBITDA in 2025 was -$222.36M.

TEM Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.